| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 24,058 | 23,438 | 23,961 | 31,070 | | Cost of Revenue | 10,233 | 10,953 | 12,949 | 13,295 | | | Gross Profit | 13,825 | 12,485 | 11,012 | 17,775 | | | Operating Expenses | | Research Development | 3,683 | 3,655 | 4,633 | 6,053 | | Selling General and Administrative | 18,738 | 11,678 | 12,259 | 14,015 | | Non Recurring | (4,202) |
-
| 4,205 | (3) | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (4,394) | (2,848) | (10,085) | (2,290) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 29 | 42 | 57 | 175 | | Earnings Before Interest And Taxes | (4,365) | (2,806) | (10,028) | (2,115) | | Interest Expense | 5 | 19 | 8 | 20 | | Income Before Tax | (4,370) | (2,825) | (10,036) | (2,135) | | Income Tax Expense | 70 | 601 | 243 | 30,224 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (4,440) | (3,426) | (10,279) | (32,359) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (4,440) | (3,426) | (10,279) | (32,359) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($4,440) | ($3,426) | ($10,279) | ($32,359) |
|
0.51% Nasdaq 0.00%
Income Statement
